Determinants of flow-mediated outward remodeling in female rodents: Respective roles of age, estrogens, and timing

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 34, Issue 6, 2014, Pages 1281-1289

  Tarhouni, Kahena ^a   Guihot, Anne Laure ^b   Vessières, Emilie ^d   Toutain, Bertrand ^a   Procaccio, Vincent ^a,d   Grimaud, Linda ^a   Loufrani, Laurent ^b   Lenfant, Francoise ^e   Arnal, Jean Francois ^e   Henrion, Daniel ^a,b,c,d,f  

^a UNIVERSITÉ D'ANGERS   (France)

^b CNRS   (France)

^c INSERM   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

^e UNIVERSITÉ PAUL SABATIER   (France)

^f Universite d'Angers   (France)

Author keywords

blood flow velocity; estrogens; ventricular remodeling

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DIAMETER; ARTERY LIGATION; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FLOW MEDIATED OUTWARD REMODELING; GENE DOSAGE; HEART VENTRICLE REMODELING; HORMONE BLOOD LEVEL; IN VITRO STUDY; INTESTINE PRESSURE; MESENTERIC ARTERY; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; SHEAR STRESS; UTERUS WEIGHT;

BLOOD FLOW VELOCITY; ESTROGENS; VENTRICULAR REMODELING;

AGING; ANIMALS; ENDOTHELIUM, VASCULAR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; MESENTERIC ARTERIES; NITRIC OXIDE SYNTHASE TYPE III; OVARIECTOMY; RATS; RATS, WISTAR; REGIONAL BLOOD FLOW; STRESS, MECHANICAL; SUPEROXIDE DISMUTASE; TIME FACTORS; VASCULAR RESISTANCE; VASODILATION;

EID: 84901491447     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.303404     Document Type: Article

References (48)

1. Uematsu M, Ohara Y, Navas JP, Nishida K, Murphy TJ, Alexander RW, Nerem RM, Harrison DG. Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am J Physiol. 1995;269(6 Pt 1):C1371-C1378.
2. Lam CF, Peterson TE, Richardson DM, Croatt AJ, d'Uscio LV, Nath KA, Katusic ZS. Increased blood flow causes coordinated upregulation of arterial eNOS and biosynthesis of tetrahydrobiopterin. Am J Physiol Heart Circ Physiol. 2006;290:H786-H793.
3. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, Nour KR, Quyyumi AA. Prognostic value of coronary vascular endothelial dysfunction. Circulation. 2002;106:653-658. (Pubitemid 34851922)
4. Green DJ, Jones H, Thijssen D, Cable NT, Atkinson G. Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter? Hypertension. 2011;57:363-369.
5. Thijssen DH, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA, Parker B, Widlansky ME, Tschakovsky ME, Green DJ. Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol. 2011;300:H2-12.
6. Pourageaud F, De Mey JG. Vasomotor responses in chronically hyperperfused and hypoperfused rat mesenteric arteries. Am J Physiol. 1998;274(4 Pt 2):H1301-H1307.
7. Dumont O, Loufrani L, Henrion D. Key role of the NO-pathway and matrix metalloprotease-9 in high blood flow-induced remodeling of rat resistance arteries. Arterioscler Thromb Vasc Biol. 2007;27:317-324. (Pubitemid 46143046)
8. Carmeliet P. Angiogenesis in life, disease and medicine. Nature. 2005;438:932-936. (Pubitemid 43093958)
9. Tuttle JL, Hahn TL, Sanders BM, Witzmann FA, Miller SJ, Dalsing MC, Unthank JL. Impaired collateral development in mature rats. Am J Physiol Heart Circ Physiol. 2002;283:H146-H155. (Pubitemid 34705334)
10. Dumont O, Pinaud F, Guihot AL, Baufreton C, Loufrani L, Henrion D. Alteration in flow (shear stress)-induced remodelling in rat resistance arteries with aging: improvement by a treatment with hydralazine. Cardiovasc Res. 2008;77:600-608. (Pubitemid 351197657)
11. Tuttle JL, Sanders BM, Burkhart HM, Fath SW, Kerr KA, Watson WC, Herring BP, Dalsing MC, Unthank JL. Impaired collateral artery development in spontaneously hypertensive rats. Microcirculation. 2002;9:343-351. (Pubitemid 135713982)
12. Belin de Chantemele EJ, Vessieres E, Guihot AL, Toutain B, Loufrani L and Henrion D. Cyclooxygenase-2 preserves flow-mediated remodeling in old obese Zucker rat mesenteric arteries. Cardiovasc Res. 2009;16: 391-402.
13. Freidja ML, Tarhouni K, Toutain B, Fassot C, Loufrani L, Henrion D. The AGE-breaker ALT-711 restores high blood flow-dependent remodeling in mesenteric resistance arteries in a rat model of type 2 diabetes. Diabetes. 2012;61:1562-1572.
14. Tarhouni K, Guihot AL, Freidja ML, Toutain B, Henrion B, Baufreton C, Pinaud F, Procaccio V, Grimaud L, Ayer A, Loufrani L, Lenfant F, Arnal JF, Henrion D. Key role of estrogens and endothelial estrogen receptor α in blood flow-mediated remodeling of resistance arteries. Arterioscler Thromb Vasc Biol. 2013;33:605-611.
15. Lenfant F, Trémollières F, Gourdy P, Arnal JF. Timing of the vascular actions of estrogens in experimental and human studies: why protective early, and not when delayed? Maturitas. 2011;68:165-173.
16. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation. 1994;89:1501-1510. (Pubitemid 24114224)
17. Arnal JF, Fontaine C, Billon-Galés A, Favre J, Laurell H, Lenfant F, Gourdy P. Estrogen receptors and endothelium. Arterioscler Thromb Vasc Biol. 2010;30:1506-1512.
18. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994;24:1468-1474. (Pubitemid 24344241)
19. Williams H, Johnson JL, Carson KG, Jackson CL. Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 2002;22:788-792. (Pubitemid 34517790)
20. Rosenfeld ME, Kauser K, Martin-McNulty B, Polinsky P, Schwartz SM, Rubanyi GM. Estrogen inhibits the initiation of fatty streaks throughout the vasculature but does not inhibit intra-plaque hemorrhage and the progression of established lesions in apolipoprotein E deficient mice. Atherosclerosis. 2002;164:251-259. (Pubitemid 35223074)
21. Wang X, Abdel-Rahman AA. Estrogen modulation of eNOS activity and its association with caveolin-3 and calmodulin in rat hearts. Am J Physiol Heart Circ Physiol. 2002;282:H2309-H2315. (Pubitemid 34663042)
22. Elhage R, Bayard F, Richard V, Holvoet P, Duverger N, Fiévet C, Arnal JF. Prevention of fatty streak formation of 17beta-estradiol is not mediated by the production of nitric oxide in apolipoprotein E-deficient mice. Circulation. 1997;96:3048-3052. (Pubitemid 27500107)
23. Billon-Galés A, Fontaine C, Douin-Echinard V, Delpy L, Berges H, Calippe B, Lenfant F, Laurell H, Guéry JC, Gourdy P, Arnal JF. Endothelial estrogen receptor-alpha plays a crucial role in the atheroprotective action of 17beta-estradiol in low-density lipoprotein receptor-deficient mice. Circulation. 2009;120:2567-2576.
24. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;297:1465-1477. (Pubitemid 46556472)
25. Ihionkhan CE, Chambliss KL, Gibson LL, Hahner LD, Mendelsohn ME, Shaul PW. Estrogen causes dynamic alterations in endothelial estrogen receptor expression. Circ Res. 2002;91:814-820. (Pubitemid 35285079)
26. Umetani M, Domoto H, Gormley AK, Yuhanna IS, Cummins CL, Javitt NB, Korach KS, Shaul PW, Mangelsdorf DJ. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat Med. 2007;13:1185-1192. (Pubitemid 47530633)
27. Bouvet C, Belin de Chantemèle E, Guihot AL, Vessières E, Bocquet A, Dumont O, Jardel A, Loufrani L, Moreau P, Henrion D. Flow-induced remodeling in resistance arteries from obese Zucker rats is associated with endothelial dysfunction. Hypertension. 2007;50:248-254. (Pubitemid 46986048)
28. Belin de Chantemele EJ, Vessieres E, Dumont O, Guihot AL, Toutain B, Loufrani L and Henrion D. Reactive oxygen species are necessary for high flow (shear stress)-induced diameter enlargement of rat resistance arteries. Microcirculation. 2009;16:391-402.
29. Vessières E, Freidja ML, Loufrani L, Fassot C, Henrion D. Flow (shear stress)-mediated remodeling of resistance arteries in diabetes. Vascul Pharmacol. 2012;57:173-178.
30. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6:389-395. (Pubitemid 30208155)
31. Najjar SS, Scuteri A, Lakatta EG. Arterial aging: is it an immutable cardiovascular risk factor? Hypertension. 2005;46:454-462. (Pubitemid 41376818)
32. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280:605-613. (Pubitemid 28502636)
33. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333. (Pubitemid 34761611)
34. Stevenson JC. Type and route of estrogen administration. Climacteric. 2009;12 Suppl 1:86-90.
35. Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med. 2009;360:606-614.
36. Rafique S, Sterling EW, Nelson LM. A new approach to primary ovarian insufficiency. Obstet Gynecol Clin North Am. 2012;39:567-586.
37. Mulvany MJ. Small artery remodeling and significance in the development of hypertension. News Physiol Sci. 2002;17:105-109.
38. Freidja ML, Vessieres E, Clere N, Desquiret V, Guihot AL, Toutain B, Loufrani L, Jardel A, Procaccio V, Faure S, Henrion D. Heme oxygenase- 1 induction restores high-blood-flow-dependent remodeling and endothelial function in mesenteric arteries of old rats. J Hypertens. 2011;29:102-112.
39. Simoncini T. Mechanisms of action of estrogen receptors in vascular cells: relevance for menopause and aging. Climacteric. 2009;12(Suppl 1):6-11.
40. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 1994;331:1056-1061. (Pubitemid 24317698)
41. Sudhir K, Chou TM, Messina LM, Hutchison SJ, Korach KS, Chatterjee K, Rubanyi GM. Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene. Lancet. 1997;349:1146-1147. (Pubitemid 27168554)
42. Lew R, Komesaroff P, Williams M, Dawood T, Sudhir K. Endogenous estrogens influence endothelial function in young men. Circ Res. 2003;93:1127-1133. (Pubitemid 37485045)
43. Gavin KM, Seals DR, Silver AE, Moreau KL. Vascular endothelial estrogen receptor alpha is modulated by estrogen status and related to endothelial function and endothelial nitric oxide synthase in healthy women. J Clin Endocrinol Metab. 2009;94:3513-3520.
44. Moien-Afshari F, Kenyon E, Choy JC, Battistini B, McManus BM, Laher I. Long-term effects of ovariectomy and estrogen replacement treatment on endothelial function in mature rats. Maturitas. 2003;45:213-223. (Pubitemid 36724877)
45. Clarkson TB, Appt SE. Controversies about HRT-lessons from monkey models. Maturitas. 2005;51:64-74.
46. Lu Y, Zhang H, Gokina N, Mandala M, Sato O, Ikebe M, Osol G, Fisher SA. Uterine artery myosin phosphatase isoform switching and increased sensitivity to SNP in a rat L-NAME model of hypertension of pregnancy. Am J Physiol Cell Physiol. 2008;294:C564-C571. (Pubitemid 351264417)
47. Henrion D, Dowell FJ, Levy BI, Michel JB. In vitro alteration of aortic vascular reactivity in hypertension induced by chronic NG-nitro-L-arginine methyl ester. Hypertension. 1996;28:361-366. (Pubitemid 26296035)
48. Dowell FJ, Henrion D, Duriez M, Michel JB. Vascular reactivity in mesenteric resistance arteries following chronic nitric oxide synthase inhibition in Wistar rats. Br J Pharmacol. 1996;117:341-346. (Pubitemid 26030289)